B Cells and Monocytes from Patients with Active Multiple Sclerosis Exhibit Increased Surface Expression of Both HERV-H Env and HERV-W Env, Accompanied by Increased Seroreactivity

Overview

Journal Retrovirology

Publisher Biomed Central

Specialty Microbiology

Date 2009 Nov 18

PMID 19917105

Citations 65

Authors

Tomasz Brudek

Tove Christensen

Lars Aagaard

Thor Petersen

Hans J Hansen

Anne Moller-Larsen

Affiliations

Soon will be listed here.

Abstract

Background: The etiology of the neurogenerative disease multiple sclerosis (MS) is unknown. The leading hypotheses suggest that MS is the result of exposure of genetically susceptible individuals to certain environmental factor(s). Herpesviruses and human endogenous retroviruses (HERVs) represent potentially important factors in MS development. Herpesviruses can activate HERVs, and HERVs are activated in MS patients.

Results: Using flow cytometry, we have analyzed HERV-H Env and HERV-W Env epitope expression on the surface of PBMCs from MS patients with active and stable disease, and from control individuals. We have also analyzed serum antibody levels to the expressed HERV-H and HERV-W Env epitopes. We found a significantly higher expression of HERV-H and HERV-W Env epitopes on B cells and monocytes from patients with active MS compared with patients with stable MS or control individuals. Furthermore, patients with active disease had relatively higher numbers of B cells in the PBMC population, and higher antibody reactivities towards HERV-H Env and HERV-W Env epitopes. The higher antibody reactivities in sera from patients with active MS correlate with the higher levels of HERV-H Env and HERV-W Env expression on B cells and monocytes. We did not find such correlations for stable MS patients or for controls.

Conclusion: These findings indicate that both HERV-H Env and HERV-W Env are expressed in higher quantities on the surface of B cells and monocytes in patients with active MS, and that the expression of these proteins may be associated with exacerbation of the disease.

Citing Articles

Patients with Irritable Bowel Syndrome Exhibit Aberrant Expression of Endogenous Retroviruses and SETDB1.

Tovo P, Ribaldone D, Caviglia G, Calvi C, Montanari P, Tizzani M Cells. 2025; 14(3).

PMID: 39936987 PMC: 11817187. DOI: 10.3390/cells14030196.

Interaction of HERVs with PAMPs in Dysregulation of Immune Response Cascade Upon SARS-CoV-2 Infections.

Turcic M, Kraljevic Pavelic S, Trivanovic D, Pavelic K Int J Mol Sci. 2025; 25(24.

PMID: 39769125 PMC: 11677760. DOI: 10.3390/ijms252413360.

Human Endogenous Retroviruses Expression in Autoimmunity.

Viret C, Bynoe M Yale J Biol Med. 2024; 97(4):521-528.

PMID: 39703611 PMC: 11650914. DOI: 10.59249/OIKF8301.

Enhanced Transcription of Human Endogenous Retroviruses and TRIM28 Downregulation in Patients with Inflammatory Bowel Disease.

Tovo P, Ribaldone D, Galliano I, Caviglia G, Dini M, Veglio V Viruses. 2024; 16(10).

PMID: 39459904 PMC: 11512322. DOI: 10.3390/v16101570.

Receptor usage of Syncytin-1: ASCT2, but not ASCT1, is a functional receptor and effector of cell fusion in the human placenta.

Stafl K, Travnicek M, Janovska A, Kucerova D, Pecnova L, Yang Z Proc Natl Acad Sci U S A. 2024; 121(44):e2407519121.

PMID: 39432789 PMC: 11536146. DOI: 10.1073/pnas.2407519121.

References

Sheremata W, Minagar A, Alexander J, Vollmer T . The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications. CNS Drugs. 2005; 19(11):909-22. DOI: 10.2165/00023210-200519110-00002. View

Simmons A . Herpesvirus and multiple sclerosis. Herpes. 2002; 8(3):60-3. View

Sutkowski N, Conrad B, Thorley-Lawson D, Huber B . Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity. 2001; 15(4):579-89. DOI: 10.1016/s1074-7613(01)00210-2. View

Sutkowski N, Chen G, Calderon G, Huber B . Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J Virol. 2004; 78(14):7852-60. PMC: 434102. DOI: 10.1128/JVI.78.14.7852-7860.2004. View

McBurney S, Young K, Ross T . Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes. Virology. 2006; 358(2):334-46. DOI: 10.1016/j.virol.2006.08.032. View

Burbelo P, Meoli E, Leahy H, Graham J, Yao K, Oh U . Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology. 2008; 5:96. PMC: 2580768. DOI: 10.1186/1742-4690-5-96. View

Christensen T, Tonjes R, zur Megede J, Boller K, Moller-Larsen A . Reverse transcriptase activity and particle production in B lymphoblastoid cell lines established from lymphocytes of patients with multiple sclerosis. AIDS Res Hum Retroviruses. 1999; 15(3):285-91. DOI: 10.1089/088922299311466. View

Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K . Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A. 2004; 101(8):2428-33. PMC: 356967. DOI: 10.1073/pnas.0308689100. View

Mangeney M, Heidmann T . Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc Natl Acad Sci U S A. 1998; 95(25):14920-5. PMC: 24551. DOI: 10.1073/pnas.95.25.14920. View

10.

Antel J, Bar-Or A . Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J Neuroimmunol. 2006; 180(1-2):3-8. DOI: 10.1016/j.jneuroim.2006.06.032. View

11.

Ordonez G, Pineda B, Garcia-Navarrete R, Sotelo J . Brief presence of varicella-zoster vral DNA in mononuclear cells during relapses of multiple sclerosis. Arch Neurol. 2004; 61(4):529-32. DOI: 10.1001/archneur.61.4.529. View

12.

Veiga A, Pattenden L, Fletcher J, Castanho M, Aguilar M . Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems. Chembiochem. 2009; 10(6):1032-44. DOI: 10.1002/cbic.200800609. View

13.

Trabattoni D, Ferrante P, Fusi M, Saresella M, Caputo D, Urnovitz H . Augmented type 1 cytokines and human endogenous retroviruses specific immune responses in patients with acute multiple sclerosis. J Neurovirol. 2000; 6 Suppl 2:S38-41. View

14.

Sundaram R, Beebe M, Kaumaya P . Structural and immunogenicity analysis of chimeric B-cell epitope constructs derived from the gp46 and gp21 subunits of the envelope glycoproteins of HTLV-1. J Pept Res. 2004; 63(2):132-40. DOI: 10.1111/j.1399-3011.2003.00113.x. View

15.

Olsson T, Sun J, Hillert J, Hojeberg B, Ekre H, Andersson G . Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis. Eur J Immunol. 1992; 22(4):1083-7. DOI: 10.1002/eji.1830220431. View

16.

Poser C, Paty D, Scheinberg L, McDonald W, Davis F, Ebers G . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13(3):227-31. DOI: 10.1002/ana.410130302. View

17.

Christensen T, Petersen T, Thiel S, Brudek T, Ellermann-Eriksen S, Moller-Larsen A . Gene-environment interactions in multiple sclerosis: innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway. J Neuroimmunol. 2006; 183(1-2):175-88. DOI: 10.1016/j.jneuroim.2006.09.014. View

18.

Bauer J, Bien C . Encephalitis and epilepsy. Semin Immunopathol. 2009; 31(4):537-44. DOI: 10.1007/s00281-009-0176-1. View

19.

Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, Sayn J . Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain. 2005; 128(Pt 7):1667-76. DOI: 10.1093/brain/awh486. View

20.

Hsiao F, Tai A, Deglon A, Sutkowski N, Longnecker R, Huber B . EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology. 2008; 385(1):261-6. DOI: 10.1016/j.virol.2008.11.025. View